Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Chronic myeloid leukemia treatment intolerance imposes additional resource and economic burden on oncology practices in the United States.
Journal: Journal of medical economics
Published: November 26, 2025
Experiences with Higher-Risk Myelodysplastic Syndromes and Improving Patient-Centered Treatment Decision-Making: A Qualitative Study of Patients, Caregivers, and Providers.
Journal: Cancer management and research
Published: August 01, 2024
The Importance of Clinical Context and Consistency in Methodology When Using Matching-Adjusted Indirect Comparisons (MAICs) to Compare Outcomes.
Journal: International journal of general medicine
Published: February 22, 2024
Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts.
Journal: Transplantation proceedings
Published: November 20, 2023
Evaluation of clinical characteristics, health care resource utilization, and cost outcomes of hemophilia A carriers and noncarriers in the United States: A real-world comparative analysis.
Journal: Journal of managed care & specialty pharmacy
Published: June 05, 2023
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 20, 2022
Real-world analysis of patients with haemophilia A and haemophilia A carriers in the United States: Demographics, clinical characteristics and costs.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 02, 2022
Gaining consensus around patient risk groups and prognostic profiles to guide CMV management among patients with solid organ transplant: Insights from a Delphi panel with SOT experts.
Journal: Clinical transplantation
Published: September 30, 2022
A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab.
Journal: Current medical research and opinion
Published: July 26, 2022
Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements.
Journal: Journal of managed care & specialty pharmacy
Published: March 28, 2022
A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors.
Journal: Journal of blood medicine
Published: August 24, 2021
Estimating Productivity Loss from Breast and Non-Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method.
Journal: MDM policy & practice
Published: June 23, 2021
Last Updated: 09/26/2026